EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Unifying serological testing for cold agglutinins

Marit Jalink iD, Femke V M Mulder, Marianne E George, Josephine M I Vos, Masja de Haas iD, Claudia C Folman, DRAIHA Consortium

Vox Sanguinis · 2025

DOI: 10.1111/vox.70069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2025. Verfasst von Marit Jalink und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Cryoglobulins, Serologic Tests, Anemia, Hemolytic, Autoimmune, Autoantibodies. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sanquin Blood Supply Foundation, Stichting Sanquin Bloedvoorziening.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Cold agglutinins (CAs) are immunoglobulin M autoantibodies that optimally bind to red blood cells at low temperatures. The clinical significance of CAs is usually characterized by the CA titre and thermal amplitude. However, there is no consensus on the optimal testing strategy. In this study, we sought to unify CA testing. Materials and Methods A survey on CA evaluation was conducted in 17 Dutch transfusion laboratories. Additionally, samples from 16 patients with CAs were used to evaluate (pre)analytical variations in test outcomes.

Results

The survey on CA evaluation revealed heterogeneity in the indications for CA workup and in (pre)analytical conditions. Titration results between EDTA plasma and serum did not differ. However, titres were higher when 2% bovine serum albumin (BSA) was present in the titration medium. Routinely collected EDTA‐blood kept at 37°C for 10 min before plasma isolation ( reheated ) showed equivalent results to plasma from blood kept at 37°C from collection through separation.

Conclusion

This study showed that different (pre)analytical conditions influence test outcomes in the characterization of CAs. Importantly, CA testing can effectively be performed with reheated blood samples, which will facilitate a more practical workflow for laboratories. International standardization of CA testing for diagnostic use is essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryoglobulinsSerologic TestsAnemia, Hemolytic, AutoimmuneAutoantibodiesHumansFemaleMale

Stichwörter der Autor:innen

autoimmune haemolytic anaemiacold agglutinin diseasecold agglutinins

Substanzen

cold agglutininsCryoglobulinsAutoantibodies

Autor:innen und Institutionen

  • Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Sanquin Research, Amsterdam, The Netherlands.
  • Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam, The Netherlands.
  • Department of Hematology, Amsterdam University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.

ORCID-Profile: Marit Jalink, Masja de Haas

Förderung

  • Sanquin Blood Supply Foundation
  • Stichting Sanquin Bloedvoorziening

Zitieren

APA

Jalink, M., Mulder, F. V. M., George, M. E., Vos, J. M. I., de Haas, M., Folman, C. C., & DRAIHA Consortium (2025). Unifying serological testing for cold agglutinins. Vox Sanguinis. https://doi.org/10.1111/vox.70069

Vancouver

Jalink M, Mulder FVM, George ME, Vos JMI, de Haas M, Folman CC, et al. Unifying serological testing for cold agglutinins. Vox Sanguinis. 2025. doi:10.1111/vox.70069

BibTeX
@article{Jalink2025,
  author = {Jalink, Marit and Mulder, Femke V M and George, Marianne E and Vos, Josephine M I and de Haas, Masja and Folman, Claudia C and DRAIHA Consortium, DRAIHA Consortium},
  title = {Unifying serological testing for cold agglutinins},
  journal = {Vox Sanguinis},
  year = {2025},
  doi = {10.1111/vox.70069}
}
Kostenlos starten →